Conclusions/interpretation At current prices, use of SGLT2is, but not GLP-1 RAs, would be cost-effective when considering only their cardiovascular and kidney disease benefits for people with type 2 diabetes
You may also have to pay for the medical provider (whether you see them or not) to review your information and write the prescription (or this may be covered but you have to pay for the medication), they may bundle fees with other services (and you may not want or need these), almost none provide the services and products you will need and they may or may not sell to you (personalized nutrition from a qualified clinician, supplements and other medications (how they may impact and what needs to be changed), additional testing, evaluation and adjustments to all aspects of the above ongoing for optimization. Evaluating whether a telehealth GLP-1 program is medically appropriate often comes down to understanding what level of support is includedand what may cost extra
Without it, youd likely drown in a sea of toxins
In particular, when your kidneys are failing, you may end up on hemodialysis
Why this is legal in 2026 Compounded semaglutide is dispensed under Section 503A of the Federal Food, Drug, and Cosmetic Act, which authorizes a state-licensed pharmacy to compound a drug for an identified individual patient with documented medical need